<DOC>
	<DOCNO>NCT02943057</DOCNO>
	<brief_summary>25 patient diagnose Cytomegalovirus ( CMV ) anterior segment infection , either uveitis endotheliitis , start 2 % guttae ganciclovir , 1 drop 5 time day 6 week . Following 6 week continuous application 2 % guttae ganciclovir , patient review clinic within 3 hour follow last application topical ganciclovir clinical feature document activity assessment . An aqueous sample 0.2ml drawn . 0.1ml send RT-PCR CMV viral load another 0.1ml send ganciclovir drug level HPLC method .</brief_summary>
	<brief_title>Topical 2 % Ganciclovir Eye Drop CMV Anterior Uveitis / Endotheliitis</brief_title>
	<detailed_description>This non-randomised single arm prospective , cross-sectional , interventional clinical study . 25 patient diagnose Cytomegalovirus ( CMV ) anterior segment infection , either uveitis endotheliitis , investigator clinic Singapore National Eye Centre , positive aqueous real time PCR ( RT-PCR ) and/or positive tetraplex PCR CMV form ganciclovir treatment past 1 month , recruit study take informed consent . This also include patient never treat antiviral therapy recurrent disease form ganciclovir treatment past 1 month . The clinical feature active disease record data collection sheet include , documentation state cornea , KPs , AC cell , flare , flare meter reading ( possible ) , central corneal thickness , Intra ocular pressure ( IOP ) C : D ratio . All patient start 2 % guttae ganciclovir , 1 drop 5 time day . 2 % Guttae ganciclovir prepare vial ganciclovir powder ganciclovir intravenous infusion use aseptic method . Following 6 week continuous application 2 % guttae ganciclovir , patient review clinic within 3 hour follow last application topical ganciclovir . 1 . Clinical feature mention documented activity assessment 2 . Following irrigation conjunctival sac 100ml N/S wash residual drug , aseptic technique practise aqueous sample 0.2ml drawn . 0.1ml send RT-PCR CMV viral load another 0.1ml send ganciclovir drug level HPLC method .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Age 21 Patients diagnosed anterior uveitis endotheliitis positive aqueous real time PCR ( RTPCR ) and/or positive tetraplex PCR Cytomegalovirus ( CMV ) Patients relapse recurrent anterior segment disease PCR positive CMV aqueous Have form ( topical , local systemic ) ganciclovir therapy past 1 month Consent undergo anterior chamber tap give aqueous tear sample study Able undergo relevant test ( e.g . laser flare cell photometry ) Able come subsequent followup visit Ability provide inform consent CMV anterior uveitis associate retinitis Other cause hypertensive anterior uveitis / endotheliitis HSV , VZV infection Patients form ( topical , local systemic ) ganciclovir therapy past1 month . Patients allergic ganciclovir Patients require systemic intravitreal ganciclovir therapy Immunocompromised patient Positive HIV , Hep B Hep C Not keen participate study Patients incapable , either law mental state , give consent right . Patients either unable unwilling keep scheduled appointment adhere aspect protocol Patients pregnant breastfeed Any specify reason determine clinical investigator .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>